Robert W. Esmond, Ph.D., is a director in Sterne Kessler’s Biotechnology & Chemical Practice Group. Rob's intellectual property law experience has principally been in the biotechnology and chemical areas. His legal experience includes counseling clients in various intellectual property matters such as patentability investigations, validity and infringement analyses, freedom to operate and FDA/ANDA/ITC practice. Rob has also prepared and prosecuted patent applications relating to pharmaceuticals, therapeutic methods, agricultural chemicals, molecular and cell biology, biomarkers, bioprinting, stem cells and antibodies. Rob is also experienced in reexamination and interference practice.
Rob's publications include scientific and legal papers prepared for the Bloomberg Law Reports, Intellectual Property and Technology Law Journal, The Intellectual Property Strategist, International Society for Stem Cell Research, Biotechnology Industry Organization, American Chemical Society, and Society of Nuclear Imaging in Drug Development. Rob is a member of the American Bar Association and the American Chemical Society.
Rob earned a Ph.D. in organic chemistry from Northeastern University in 1981, where he researched the organic synthesis of natural products. He then spent one year at the University of Maryland as a Postdoctoral Research Associate working on the organic synthesis of antitumor compounds.
Before joining the firm, Rob was employed by a large multinational corporation as a Senior Research Chemist. Rob's research involved natural products chemistry and organic synthesis.
- American Bar Association
- American Chemical Society